NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-276-2008-0-US-02 MAGNETIC RESONANCE SPECIMEN EVALUATION USING MULTIPLE PULSED FIELD GRADIENT SEQUENCES WITH A WAVENUMBER MAGNITUDE LOCAL MINIMUM AND RESTRICTED COMPARTMENT ESTIMATION US ORD 12/539,462 8704515 Issued PDF
NCI E-014-2007-0-US-17 Smoothened Polypeptides and Methods of Use US National Stage 12/513,091 8198402 Abandoned PDF
NIDDK E-098-2007-0-US-12 Synthetic Macrolides Compounds And Methods For Treating Cancer US National Stage 12/526,477 Abandoned
NCI E-086-2004-0-JP-16 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them JP DIV 2009-184500 Abandoned
NIA E-251-1997-0-JP-28 INSULIN PRODUCING CELLS DIFFERENTIATED FROM NON-INSULIN PRODUCING CELLS BY GLP-1 AND EXENDIN-4 AND USES THEREOF JP DIV 2009-184807 Abandoned
NIA E-088-2007-1-FR-11 Methods For Modulating Embryonic Stem Cell Differentiation FR EP 08732853.0 Issued
NIA E-088-2007-1-DE-10 Methods For Modulating Embryonic Stem Cell Differentiation DE EP 08732853.0 Issued
NIA E-088-2007-1-GB-12 Methods For Modulating Embryonic Stem Cell Differentiation GB EP 08732853.0 Issued
NHGRI E-272-2008-0-AU-03 Use of ERBB4 as a Prognostic and Therapeutic Marker for Melanoma AU National Stage 2009314534 Abandoned
NHGRI E-272-2008-0-PCT-02 Use of ERBB4 as a Prognostic and Therapeutic Marker for Melanoma PCT PCT PCT/US2009/053005 Expired
NHGRI E-272-2008-0-EP-04 Use of ERBB4 as a Prognostic and Therapeutic Marker for Melanoma EP National Stage 09791233.1 Abandoned
NIAMS E-224-2010-1-CA-09 METHODS OF OBTAINING MESENCHYMAL PROGENITOR CELLS CA DIV 2967583 Issued
NIAMS E-224-2010-1-EP-06 Regenerative Tissue Grafts and Methods of Making Same EP National Stage 09829422.6 Issued
NIAMS E-224-2010-1-CA-08 Regenerative Tissue Grafts and Methods of Making Same CA National Stage 2744559 Issued
NCI E-153-2008-0-GB-09 Radioprotectants Targeting Thrombospondin-1 And CD47 GB EP 09791202.6 Issued
NCI E-153-2008-0-DE-07 Radioprotectants Targeting Thrombospondin-1 And CD47 DE EP 09791202.6 Issued
NCI E-153-2008-0-FR-08 Radioprotectants Targeting Thrombospondin-1 And CD47 FR EP 09791202.6 Issued
NCI E-153-2008-0-EP-05 Radioprotectants Targeting Thrombospondin-1 And CD47 EP National Stage 09791202.6 Issued
NIAMS E-224-2010-1-AU-04 Regenerative Tissue Grafts and Methods of Making Same AU National Stage 2009320446 Issued
NCI E-153-2008-0-AU-03 Radioprotectants Targeting Thrombospondin-1 And CD47 AU National Stage 2009279676 Issued
NCI E-014-2007-0-MO-12 SMOOTHENED POLYPEPTIDES AND METHODS OF USE MO National Stage J/000364 Abandoned
NIAMS E-224-2010-1-US-02 Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side US National Stage 13/129,636 8652458 Issued PDF
NIAMS E-224-2010-1-PCT-01 Regenerative Tissue Grafts and Methods of Making Same PCT PCT PCT/US2009/004482 Expired
NCI E-153-2008-0-PCT-02 Radioprotectants Targeting Thrombospondin-1 And CD47 PCT PCT PCT/US2009/052902 Expired
NIAMS E-224-2010-1-AU-05 Regenerative Tissue Grafts and Methods of Making Same AU DIV 2015258180 Abandoned
NIDCR E-015-2002-3-AU-08 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS AU DIV 2009206153 Expired
NIDCD E-222-2003-1-US-06 Variants of Human Taste Receptor Genes US CON 12/534,505 8309701 Expired PDF
NIDDK E-285-2008-0-CA-04 A3 Adenosine Receptor Antagonists and Partial Agonists CA National Stage 2732320 Abandoned
NIDDK E-285-2008-0-EP-05 A3 Adenosine Receptor Antagonists and Partial Agonists EP National Stage 09791060.8 Abandoned
NIDDK E-285-2008-0-AU-03 A3 Adenosine Receptor Antagonists And Partial Agonists AU National Stage 2009276411 Abandoned
NIDDK E-285-2008-0-JP-06 A3 Adenosine Receptor Antagonists and Partial Agonists JP National Stage 2011-521360 Abandoned
NCI E-161-2008-0-PCT-02 Antiviral Activity of the Protein Scytovirin (SVN) and Method of Use PCT PCT PCT/US2009/004420 Expired
NCI E-211-2008-0-PCT-02 A Fully Human Monoclonal Antibody To Human NKG2D PCT PCT PCT/US2009/52387 Expired
NIDDK E-285-2008-0-PCT-02 Truncated (N)-Methanocarba Adenosine Derivatives As A3 Receptor Antagonists PCT PCT PCT/US2009/52439 Expired
NIAID E-229-2003-2-US-23 GITR Ligand And GITR Ligand-Related Molecules and Antibodies And Uses Thereof US DIV 12/550,244 Abandoned
NCI E-161-2008-0-EP-04 Antiviral Activity of the Protein Scytovirin (SVN) and Method of Use EP National Stage 09789047.9 Abandoned
NCI E-161-2008-0-JP-05 Antiviral Activity of the Protein Scytovirin (SVN) and Method of Use JP National Stage 2011-521126 Abandoned
NCI E-263-2009-0-US-01 ANTIANGIOGENIC SMALL MOLECULES, AND METHODS OF USE US 61/230,667 Abandoned
NICHD E-107-2003-0-US-22 Cholesterol- Containing Compounds And Their Use As Immunogens Against Borrelia Burgdorferi US DIV 12/511,337 Abandoned
NCI E-247-2008-0-US-02 Lasonolide Compounds as Reagents for Inducing Premature Chromosome Condensation and Methods of Treating Disorders US ORD 12/462,005 8278100 Abandoned PDF
NCI E-185-2008-0-US-02 HMGN Polypeptides As Immune Enhancers And HMGN Antagonists As Immune Suppressants US ORD 12/509,088 8227417 Issued PDF
NCI E-144-2002-1-US-07 HUMAN IMMUNODEFICIENCY VIRUS- NEUTRALIZING ANTIBODIES WITH IMPROVED BREADTH AND POTENCY US DIV 12/508,913 8110192 Abandoned PDF
NHLBI E-248-2009-0-PCT-01 X-Ray Scattering Imaging PCT PCT PCT/US2009/051642 Expired
NIDDK E-213-2009-1-US-01 Methods Of Modulating Hepatits C Virus Infection US 61/228,496 Abandoned
NIAID E-275-2008-2-PCT-01 Use Of Mono-Amine Oxidase Inhibitors To Prevent Herpes Simpex Virus Infection And Reactiviation From Latency PCT PCT COMB PCT/US2009/051557 Expired
NIAID E-275-2008-2-EP-03 Preventing or Treating Viral Infection Using An Inhibitor of The LSD1 Protein, A MAO Inhibitor or an Inhibitor of LSD1 And A MAO Inhibitor EP National Stage 09790772.9 Abandoned
NICHD E-240-2008-0-PCT-02 Detection and Quantification of HIV Antigen PCT PCT PCT/US2009/051440 Expired
NCI E-259-1994-3-JP-10 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST TUMOR-ASSOCIATED ANTIGENS JP DIV 2009-171254 Abandoned
NHGRI E-090-2010-0-PCT-02 METHODS OF DIAGNOSING AND PROGNOSING CANCER SUCH AS MELANOMA AND METHODS OF SELECTING COMPOUNDS TO TREAT MELANOMA. PCT PCT PCT/US2009/004254 Expired
NHGRI E-090-2010-0-AU-03 METHODS OF DIAGNOSING AND PROGNOSING CANCER SUCH AS MELANOMA AND METHODS OF SELECTING COMPOUNDS TO TREAT MELANOMA. AU National Stage 2009274563 Abandoned